These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 35732250)

  • 21. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy.
    Zhao W; Li K; Li L; Wang R; Lei Y; Yang H; Sun L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy.
    Kunde SS; Wairkar S
    Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.
    de la Torre P; Pérez-Lorenzo MJ; Alcázar-Garrido Á; Flores AI
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery.
    Azhdari MH; Goodarzi N; Doroudian M; MacLoughlin R
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Applications of Stem Cell-Derived Exosomes.
    Abdulmalek OAAY; Husain KH; AlKhalifa HKAA; Alturani MMAB; Butler AE; Moin ASM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.
    Duan H; Wang L; Wang S; He Y
    Nanomedicine (Lond); 2023 Aug; 18(19):1281-1303. PubMed ID: 37753724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomimetic camouflaged nanoparticles with selective cellular internalization and migration competences.
    Jiménez-Jiménez C; Moreno-Borrallo A; Dumontel B; Manzano M; Vallet-Regí M
    Acta Biomater; 2023 Feb; 157():395-407. PubMed ID: 36476646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell membrane-based biomimetic nanosystems for advanced drug delivery in cancer therapy: A comprehensive review.
    Zhao J; Ruan J; Lv G; Shan Q; Fan Z; Wang H; Du Y; Ling L
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112503. PubMed ID: 35429736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered biomembrane-derived nanoparticles for nanoscale theranostics.
    Wu Z; Zhang H; Yan J; Wei Y; Su J
    Theranostics; 2023; 13(1):20-39. PubMed ID: 36593970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinspired exosome-like therapeutics and delivery nanoplatforms.
    Lu M; Huang Y
    Biomaterials; 2020 Mar; 242():119925. PubMed ID: 32151860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.